CS MEDICA announces that their 6 CANNANSEN®CBD Medical Products has been successfully registered at MHRA for Sales in United Kingdom.
CS MEDICA A/S (”CS MEDICA” or the ”Company”) announces today that their 6 CANNANSEN® CBD Medical Products has been successfully registered at Medicines and Healthcare products Regulatory Agency ("MHRA") in United Kingdom. The 6 CANNANSEN® CBD Medical Products has been through a registration procedure at MHRA – the process is finalized and the products are now ready for Sale in United Kingdom.The registration of the 6 CANNANSEN® CBD medicinal products with the MHRA enables CS MEDICA to market and sell their 6 CANNANSEN® CBD medicinal products in the UK. The registration has further